Following Hungary’s example, which was the first European Union member state to purchase the Russian Sputnik V vaccine, an increasing number of other countries are also announcing deals to acquire it, with the German federal state of Bavaria serving as the latest example, daily Magyar Hírlap reports.
Bavaria could buy millions of the Sputnik V vaccine developed in Russia against the new type of coronavirus (SARS-CoV-2) if the EU allows it, Prime Minister Markus Söder said after a meeting of the provincial government. He added that Bavarian Health Minister Klaus Holetschek would sign a preliminary contract on Wednesday to buy 2.5 million doses of Sputnik V vaccine.
The contracting partner is a company from Illertissen, Bavaria, he added, referring to a pharmaceutical company called R-Pharm, which plans to start importing a Russian-developed vaccine with an investment of € 0 million and undertake the so-called final release of production batches.
Söder emphasized that the conclusion of the final contract was conditional on a European Medicines Agency (EMA) license to market Sputnik V.
As Remix News reported at the time, on the last day of March, German Chancellor Angela Merkel, Russian President Vladimir Putin and French President Emmanuel Macron discussed the prospects that Europe could authorize the Russian Sputnik V vaccine were discussed, as well as the possibility of transporting Russian vaccines and conducting joint European-Russian production in the territory of the EU.
Earlier in March, Russia also struck a deal to produce 10 million doses of the vaccine in Italy.
